Precept Management LLC Cue Biopharma, Inc. Transaction History

Precept Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $154,350 - $429,800	-35,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $1.29 Million - $1.85 Million	-115,000 Reduced 76.67%	35,000 $427,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $639,700 - $1 Million	-42,505 Reduced 22.08%	150,000 $2.26 Million
Q2 2020 Aug 14, 2020	SELL	$12.7 - $30.73 $222,186 - $537,621	-17,495 Reduced 8.33%	192,505 $4.72 Million
Q1 2020 May 15, 2020	BUY	$9.85 - $22.27 $394,000 - $890,800	40,000 Added 23.53%	210,000 $2.98 Million
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $1.2 Million - $2.97 Million	170,000 New	170,000 $2.7 Million

13.9M

56.1K

11.1K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $61.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

Stay updated on Precept Management LLC with notifications on news.